Literature DB >> 28601916

Thyroid Carcinoma in a Child with Activated Phosphoinositide 3-Kinase δ Syndrome: Somatic Effect of a Germline Mutation.

Giorgia Bucciol1,2, Lien Willems3, Esther Hauben4, Anne Uyttebroeck3, Marijke Proesmans3, Isabelle Meyts5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28601916     DOI： 10.1007/s10875-017-0407-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  19 in total

1.  Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome.

Authors:  Zohreh Nademi; Mary A Slatter; Christopher C Dvorak; Benedicte Neven; Alain Fischer; Felipe Suarez; Claire Booth; Kanchan Rao; Alexandra Laberko; Julia Rodina; Yves Bertrand; Sylwia Kołtan; Robert Dębski; Terence Flood; Mario Abinun; Andrew R Gennery; Sophie Hambleton; Stephan Ehl; Andrew J Cant
Journal:  J Allergy Clin Immunol       Date:  2016-11-12       Impact factor: 10.793

2.  Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.

Authors:  Carol Sawyer; Justin Sturge; Dorothy C Bennett; Michael J O'Hare; William E Allen; Jennifer Bain; Gareth E Jones; Bart Vanhaesebroeck
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

3.  Morphoproteomics demonstrates activation of mammalian target of rapamycin pathway in papillary thyroid carcinomas with nuclear translocation of MTOR in aggressive histological variants.

Authors:  Jing Liu; Robert E Brown
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

Review 4.  PI3K/Akt/mTOR: A promising therapeutic target for non-medullary thyroid carcinoma.

Authors:  Mirela S Petrulea; Theo S Plantinga; Jan W Smit; Carmen E Georgescu; Romana T Netea-Maier
Journal:  Cancer Treat Rev       Date:  2015-06-26       Impact factor: 12.111

5.  Childhood and adolescent cancer statistics, 2014.

Authors:  Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-31       Impact factor: 508.702

6.  Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Authors:  Zhi Liu; Peng Hou; Meiju Ji; Haixia Guan; Kimberly Studeman; Kirk Jensen; Vasily Vasko; Adel K El-Naggar; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

7.  Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Authors:  Carrie L Lucas; Hye Sun Kuehn; Fang Zhao; Julie E Niemela; Elissa K Deenick; Umaimainthan Palendira; Danielle T Avery; Leen Moens; Jennifer L Cannons; Matthew Biancalana; Jennifer Stoddard; Weiming Ouyang; David M Frucht; V Koneti Rao; T Prescott Atkinson; Anahita Agharahimi; Ashleigh A Hussey; Les R Folio; Kenneth N Olivier; Thomas A Fleisher; Stefania Pittaluga; Steven M Holland; Jeffrey I Cohen; Joao B Oliveira; Stuart G Tangye; Pamela L Schwartzberg; Michael J Lenardo; Gulbu Uzel
Journal:  Nat Immunol       Date:  2013-10-28       Impact factor: 25.606

Review 8.  PI3Kδ and primary immunodeficiencies.

Authors:  Carrie L Lucas; Anita Chandra; Sergey Nejentsev; Alison M Condliffe; Klaus Okkenhaug
Journal:  Nat Rev Immunol       Date:  2016-09-12       Impact factor: 53.106

9.  The role of phosphoinositide 3-kinase subunits in chronic thyroiditis.

Authors:  Katarzyna Wojciechowska-Durczynska; Kinga Krawczyk-Rusiecka; Anna Cyniak-Magierska; Arkadiusz Zygmunt; Stanisław Sporny; Andrzej Lewinski
Journal:  Thyroid Res       Date:  2012-12-21

Review 10.  The PI3K/Akt Pathway in Tumors of Endocrine Tissues.

Authors:  Helen Louise Robbins; Angela Hague
Journal:  Front Endocrinol (Lausanne)       Date:  2016-01-11       Impact factor: 5.555
View more
  2 in total

1.  Warts and DADA2: a Mere Coincidence?

Authors:  Katrijn Arts; Jenna R E Bergerson; Amanda K Ombrello; Morgan Similuk; Andrew J Oler; Anahita Agharahimi; Emily M Mace; Mike Hershfield; Carine Wouters; Lien De Somer; Marie-Anne Morren; Rebeca Perez-de Diego; Leen Moens; Alexandra F Freeman; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2018-11-01       Impact factor: 8.542

Review 2.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.